Compounds > 1-oxyl-2,2,6,6-tetramethyl 4-piperidinyl nicotinate
Page last updated: 2024-12-08
1-oxyl-2,2,6,6-tetramethyl 4-piperidinyl nicotinate
Description
You're asking about **1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl nicotinate** (often shortened to **TEMPONE-nicotinate** or **TEMPON-nicotinate**).
This compound is a **nitroxide spin label**, a molecule that contains a nitrogen-centered free radical known as a nitroxide. This free radical is paramagnetic, meaning it has an unpaired electron that creates a strong magnetic field.
Here's why TEMPONE-nicotinate is important for research:
* **Spin Labeling:** It can be used to investigate molecular interactions and dynamics in biological systems. The nitroxide group in TEMPONE-nicotinate interacts with the environment surrounding it, providing information about its location, mobility, and interactions.
* **Electron Paramagnetic Resonance (EPR) Spectroscopy:** EPR spectroscopy is a technique that exploits the magnetic properties of unpaired electrons. By attaching TEMPONE-nicotinate to molecules of interest, researchers can use EPR to study:
* **Protein Structure and Dynamics:** TEMPONE-nicotinate can be used to study the structure and dynamics of proteins, including conformational changes, protein folding, and enzyme kinetics.
* **Membrane Properties:** TEMPONE-nicotinate can be used to study the properties of cell membranes, such as fluidity, phase transitions, and the movement of lipids and proteins within the membrane.
* **Drug Interactions:** TEMPONE-nicotinate can be used to study the interactions of drugs with biological systems, including their binding sites and mechanisms of action.
* **Other Applications:** Beyond EPR, TEMPONE-nicotinate can also be used in other research areas like:
* **Fluorescence Microscopy:** The nitroxide group can quench fluorescence, allowing for the study of biomolecule dynamics in cells.
* **Biomedical Imaging:** TEMPONE-nicotinate can be used for in vivo imaging in research.
**Key Benefits of TEMPONE-nicotinate:**
* **High Sensitivity:** Nitroxide radicals are highly sensitive to their environment, allowing for detailed analysis of molecular interactions.
* **Versatility:** TEMPONE-nicotinate can be chemically modified to target specific molecules or cellular compartments.
* **Non-invasive:** TEMPONE-nicotinate can be used to study biological systems without disrupting their natural function.
**In Summary:** TEMPONE-nicotinate is a valuable tool for researchers working in a variety of fields, including biochemistry, biophysics, and drug discovery. Its unique properties allow for the investigation of molecular interactions and dynamics at a very detailed level.
1-oxyl-2,2,6,6-tetramethyl 4-piperidinyl nicotinate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 189135 |
MeSH ID | M0106126 |
Synonyms (6)
Synonym |
spin label rno |
52286-91-6 |
1-oxyl-2,2,6,6-tetramethyl 4-piperidinyl nicotinate |
1-piperidinyloxy, 2,2,6,6-tetramethyl-4-((3-pyridinylcarbonyl)oxy)- |
DTXSID70966664 |
{2,2,6,6-tetramethyl-4-[(pyridine-3-carbonyl)oxy]piperidin-1-yl}oxidanyl |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.27
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.27 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.21 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |